FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid epidemic.